Researchers are excited about the medication , a novel dual treatment showing promising data in clinical trials for weight reduction . It acts by impacting two systems: GLP-1 and GIP, these, when activated , support control cravings and enhance calorie burn. Early observations suggest noteworthy weight management and potential advantages for patien